Catherine Isted has joined cell-based therapeutics company ReNeuron as chief financial officer.
Isted was previously head of corporate development and investor relations in the finance leadership team at Oxford Biomedica, and is a former partner in the healthcare equities team at Peel Hunt. She has also held research analyst and equity sales positions in the healthcare teams at Morgan Stanley, ABN AMRO and Nomura.
Iain Ross, ReNeuron chair, commented: “Catherine has an excellent knowledge of the healthcare sector and is highly skilled in equity capital markets, M&A and strategic business development. She will be a fantastic addition to the ReNeuron board and I am thoroughly looking forward to working alongside her.”
Related Posts
-
December 13, 2021
Paul, a former CFO at Amazon Studios and streaming platform Hulu, will take over from Brian Roberts on 3 January.
-
January 14, 2022
Hough is Foxtons’ director of finance and company secretary, and will take over from current CFO Richard Harris in April.
-
March 7, 2022
Gorman joined Shell in 1999 and has held several leadership roles in finance. She will take over from current CFO Jessica Uhl on 1 April.
-
July 11, 2022
Current CFO Kevin Ozan is to become senior executive vice president, strategic initiatives, in September, and plans to retire next year.